MILAN ― Numerous unresolved questions surround progressive pulmonary fibrosis (PPF) treatment, according to Elisabeth Bendstrup, MD, PhD, a researcher and clinical professor in the Department of ...

Pulmonary fibrosis is a devastating disease that leads to progressive scarring of the lungs. Fibrotic scarring causes lung tissue stiffness, which leads to breathing difficulties and reduces oxygen ...

Yale researchers have identified a potential treatment for idiopathic pulmonary fibrosis, or IPF, which can reverse lung scarring. In a study recently published in “JCI Insight,” researchers from the ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

LIBERTY, Miss, Jan. 3, 2024 /PRNewswire/ -- Vitti Labs™, an AATB accredited tissue bank and life sciences company based in Liberty, MO, announced today that VL-PX10 and VL-P22, a first in class ...

Pulmonary fibrosis (PF) is a type of interstitial lung disease that causes lung tissue to scar, thicken, and stiffen. It can make breathing difficult and interfere with oxygen absorption into the ...

A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life prognosis ...

Dr. Thomas Barker is advancing an antibody treatment that shows early signs of halting disease progression as well as generating new lung tissue As soon as we saw the effect the antibody was having in ...

Please provide your email address to receive an email when new articles are posted on . The FDA based nerandomilast’s approval on results from two trials, one of which was the FIBRONEER-IPF trial.

Hundreds of diseases that cause scarring or inflammation in your lungs are known as interstitial lung disease (ILD)—also called pulmonary fibrosis. All of these diseases make it more difficult to ...